English
简体中文
Total: £ 56.28
Published Date: 2024-10-17 | Pages: 96 | Tables: 203 | Pharma & Healthcare
Hib vaccine is a vaccine to prevent invasive diseases caused by Hib, such as meningitis, pneumonia, epiglottitis, sepsis, cellulitis, pericarditis, myelitis, etc.
The global market for Hib Vaccine was estimated to be worth US$ 1154 million in 2023 and is forecast to a readjusted size of US$ 1730.6 million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hib Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hib Vaccine by region & country, by Type, and by Application.
The Hib Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hib Vaccine.
Market Segmentation
By Company
Bharat Biotech
Glaxosmithkline
Kangtai Bio
Lanzhou Institute
Olin Bio
Sanofi Pasteur
Watson Bio
Zhifei Bio
Segment by Type:
Hib Vaccine
Multiple Seedlings
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hib Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hib Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hib Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Hib Vaccine Product Introduction
1.2 Global Hib Vaccine Market Size Forecast
1.2.1 Global Hib Vaccine Sales Value (2019-2030)
1.2.2 Global Hib Vaccine Sales Volume (2019-2030)
1.2.3 Global Hib Vaccine Sales Price (2019-2030)
1.3 Hib Vaccine Market Trends & Drivers
1.3.1 Hib Vaccine Industry Trends
1.3.2 Hib Vaccine Market Drivers & Opportunity
1.3.3 Hib Vaccine Market Challenges
1.3.4 Hib Vaccine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hib Vaccine Players Revenue Ranking (2023)
2.2 Global Hib Vaccine Revenue by Company (2019-2024)
2.3 Global Hib Vaccine Players Sales Volume Ranking (2023)
2.4 Global Hib Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Hib Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Hib Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Hib Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Hib Vaccine
2.9 Hib Vaccine Market Competitive Analysis
2.9.1 Hib Vaccine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Hib Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hib Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hib Vaccine
3.1.2 Multiple Seedlings
3.2 Global Hib Vaccine Sales Value by Type
3.2.1 Global Hib Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Hib Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Hib Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Hib Vaccine Sales Volume by Type
3.3.1 Global Hib Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Hib Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Hib Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Hib Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Hib Vaccine Sales Value by Application
4.2.1 Global Hib Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Hib Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Hib Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Hib Vaccine Sales Volume by Application
4.3.1 Global Hib Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Hib Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Hib Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Hib Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Hib Vaccine Sales Value by Region
5.1.1 Global Hib Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Hib Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Hib Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Hib Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Hib Vaccine Sales Volume by Region
5.2.1 Global Hib Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Hib Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Hib Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Hib Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Hib Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Hib Vaccine Sales Value, 2019-2030
5.4.2 North America Hib Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Hib Vaccine Sales Value, 2019-2030
5.5.2 Europe Hib Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Hib Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Hib Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Hib Vaccine Sales Value, 2019-2030
5.7.2 South America Hib Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hib Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Hib Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hib Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Hib Vaccine Sales Value
6.2.1 Key Countries/Regions Hib Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Hib Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Hib Vaccine Sales Value, 2019-2030
6.3.2 United States Hib Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Hib Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Hib Vaccine Sales Value, 2019-2030
6.4.2 Europe Hib Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Hib Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Hib Vaccine Sales Value, 2019-2030
6.5.2 China Hib Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Hib Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Hib Vaccine Sales Value, 2019-2030
6.6.2 Japan Hib Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Hib Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Hib Vaccine Sales Value, 2019-2030
6.7.2 South Korea Hib Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Hib Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Hib Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Hib Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Hib Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Hib Vaccine Sales Value, 2019-2030
6.9.2 India Hib Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Hib Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bharat Biotech
7.1.1 Bharat Biotech Company Information
7.1.2 Bharat Biotech Introduction and Business Overview
7.1.3 Bharat Biotech Hib Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Bharat Biotech Hib Vaccine Product Offerings
7.1.5 Bharat Biotech Recent Development
7.2 Glaxosmithkline
7.2.1 Glaxosmithkline Company Information
7.2.2 Glaxosmithkline Introduction and Business Overview
7.2.3 Glaxosmithkline Hib Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Glaxosmithkline Hib Vaccine Product Offerings
7.2.5 Glaxosmithkline Recent Development
7.3 Kangtai Bio
7.3.1 Kangtai Bio Company Information
7.3.2 Kangtai Bio Introduction and Business Overview
7.3.3 Kangtai Bio Hib Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Kangtai Bio Hib Vaccine Product Offerings
7.3.5 Kangtai Bio Recent Development
7.4 Lanzhou Institute
7.4.1 Lanzhou Institute Company Information
7.4.2 Lanzhou Institute Introduction and Business Overview
7.4.3 Lanzhou Institute Hib Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Lanzhou Institute Hib Vaccine Product Offerings
7.4.5 Lanzhou Institute Recent Development
7.5 Olin Bio
7.5.1 Olin Bio Company Information
7.5.2 Olin Bio Introduction and Business Overview
7.5.3 Olin Bio Hib Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Olin Bio Hib Vaccine Product Offerings
7.5.5 Olin Bio Recent Development
7.6 Sanofi Pasteur
7.6.1 Sanofi Pasteur Company Information
7.6.2 Sanofi Pasteur Introduction and Business Overview
7.6.3 Sanofi Pasteur Hib Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Sanofi Pasteur Hib Vaccine Product Offerings
7.6.5 Sanofi Pasteur Recent Development
7.7 Watson Bio
7.7.1 Watson Bio Company Information
7.7.2 Watson Bio Introduction and Business Overview
7.7.3 Watson Bio Hib Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Watson Bio Hib Vaccine Product Offerings
7.7.5 Watson Bio Recent Development
7.8 Zhifei Bio
7.8.1 Zhifei Bio Company Information
7.8.2 Zhifei Bio Introduction and Business Overview
7.8.3 Zhifei Bio Hib Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Zhifei Bio Hib Vaccine Product Offerings
7.8.5 Zhifei Bio Recent Development
8 Industry Chain Analysis
8.1 Hib Vaccine Industrial Chain
8.2 Hib Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hib Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Hib Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Hib Vaccine Market Trends
Table 2. Hib Vaccine Market Drivers & Opportunity
Table 3. Hib Vaccine Market Challenges
Table 4. Hib Vaccine Market Restraints
Table 5. Global Hib Vaccine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Hib Vaccine Revenue Market Share by Company (2019-2024)
Table 7. Global Hib Vaccine Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Hib Vaccine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Hib Vaccine Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Hib Vaccine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Hib Vaccine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Hib Vaccine
Table 13. Global Hib Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hib Vaccine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Hib Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Hib Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Hib Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Hib Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Hib Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Hib Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Hib Vaccine Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Hib Vaccine Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Hib Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Hib Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Hib Vaccine Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Hib Vaccine Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Hib Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Hib Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Hib Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Hib Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Hib Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Hib Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Hib Vaccine Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Hib Vaccine Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Hib Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Hib Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Hib Vaccine Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Hib Vaccine Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Hib Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Hib Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Hib Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Hib Vaccine Sales Value by Region (2019-2024) & (%)
Table 44. Global Hib Vaccine Sales Value by Region (2025-2030) & (%)
Table 45. Global Hib Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Hib Vaccine Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Hib Vaccine Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Hib Vaccine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Hib Vaccine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Hib Vaccine Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Hib Vaccine Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Hib Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Hib Vaccine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Hib Vaccine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Hib Vaccine Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Hib Vaccine Sales Volume, (2025-2030) & (K Units)
Table 57. Bharat Biotech Company Information
Table 58. Bharat Biotech Introduction and Business Overview
Table 59. Bharat Biotech Hib Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Bharat Biotech Hib Vaccine Product Offerings
Table 61. Bharat Biotech Recent Development
Table 62. Glaxosmithkline Company Information
Table 63. Glaxosmithkline Introduction and Business Overview
Table 64. Glaxosmithkline Hib Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Glaxosmithkline Hib Vaccine Product Offerings
Table 66. Glaxosmithkline Recent Development
Table 67. Kangtai Bio Company Information
Table 68. Kangtai Bio Introduction and Business Overview
Table 69. Kangtai Bio Hib Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Kangtai Bio Hib Vaccine Product Offerings
Table 71. Kangtai Bio Recent Development
Table 72. Lanzhou Institute Company Information
Table 73. Lanzhou Institute Introduction and Business Overview
Table 74. Lanzhou Institute Hib Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Lanzhou Institute Hib Vaccine Product Offerings
Table 76. Lanzhou Institute Recent Development
Table 77. Olin Bio Company Information
Table 78. Olin Bio Introduction and Business Overview
Table 79. Olin Bio Hib Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Olin Bio Hib Vaccine Product Offerings
Table 81. Olin Bio Recent Development
Table 82. Sanofi Pasteur Company Information
Table 83. Sanofi Pasteur Introduction and Business Overview
Table 84. Sanofi Pasteur Hib Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Sanofi Pasteur Hib Vaccine Product Offerings
Table 86. Sanofi Pasteur Recent Development
Table 87. Watson Bio Company Information
Table 88. Watson Bio Introduction and Business Overview
Table 89. Watson Bio Hib Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Watson Bio Hib Vaccine Product Offerings
Table 91. Watson Bio Recent Development
Table 92. Zhifei Bio Company Information
Table 93. Zhifei Bio Introduction and Business Overview
Table 94. Zhifei Bio Hib Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Zhifei Bio Hib Vaccine Product Offerings
Table 96. Zhifei Bio Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Hib Vaccine Downstream Customers
Table 100. Hib Vaccine Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Hib Vaccine Product Picture
Figure 2. Global Hib Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Hib Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Hib Vaccine Sales Volume (2019-2030) & (K Units)
Figure 5. Global Hib Vaccine Sales Price (2019-2030) & (US$/Unit)
Figure 6. Hib Vaccine Report Years Considered
Figure 7. Global Hib Vaccine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Hib Vaccine Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Hib Vaccine Revenue in 2023
Figure 10. Hib Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Hib Vaccine Picture
Figure 12. Multiple Seedlings Picture
Figure 13. Global Hib Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Hib Vaccine Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Hib Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Hib Vaccine Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Hib Vaccine Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Clinic
Figure 20. Global Hib Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Hib Vaccine Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Hib Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 23. Global Hib Vaccine Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Hib Vaccine Price by Application (2019-2030) & (US$/Unit)
Figure 25. North America Hib Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Hib Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Hib Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Hib Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Hib Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Hib Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Hib Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Hib Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Hib Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Hib Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Hib Vaccine Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Hib Vaccine Sales Volume (%), (2019-2030)
Figure 37. United States Hib Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Hib Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Hib Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Hib Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Hib Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Hib Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 43. China Hib Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Hib Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 45. China Hib Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Hib Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Hib Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Hib Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Hib Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Hib Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Hib Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Hib Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Hib Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Hib Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 55. India Hib Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Hib Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 57. India Hib Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 58. Hib Vaccine Industrial Chain
Figure 59. Hib Vaccine Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
